![Eric Krauland](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Eric M.
Krauland is President & Chief Scientific Officer at Adimab LLC since 2022.
Dr. Krauland holds a doctorate from the Massachusetts Institute of Technology and an undergraduate degree from The Johns Hopkins University.
Eric Krauland active positions
| Companies | Position | Start |
|---|---|---|
Adimab LLC
 Adimab LLC BiotechnologyHealth Technology Operates as a biologics discovery and engineering company that develops antibody drugs | President | 2022-05-08 |
Training of Eric Krauland
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Adimab LLC
Adimab LLC BiotechnologyHealth Technology Operates as a biologics discovery and engineering company that develops antibody drugs | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Eric Krauland
Choose MarketScreener 
